🇺🇸 FDA
Patent

US 10385085

Crystal forms of sialic acid or salt or solvate thereof

granted A61PA61P31/12A61P31/16

Quick answer

US patent 10385085 (Crystal forms of sialic acid or salt or solvate thereof) held by Ultragenyx Pharmaceutical Inc. expires Mon Aug 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ultragenyx Pharmaceutical Inc.
Grant date
Tue Aug 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P31/12, A61P31/16